*EMBARGOED All research presented at the 2020 ACG Annual Scientific Meeting and Postgraduate Course is strictly embargoed until Monday, October 26, 2020, at 8:00 am EDT.

Daryl Ramai, MD
Daryl Ramai, MD

Oral 4 Endoscopic Resection of T1b Esophageal Adenocarcinoma Is Comparable to Esophagectomy: A Surveillance, Epidemiology, and End Results Database Study

Author Insight from Daryl Ramai, MD, The Brooklyn Hospital Center

What’s new here and important for clinicians?

  • Our study shows no significant difference in survival outcomes following surgical and endoscopic resection of T1b esophageal adenocarcinoma.
  • Endoscopic removal of T1b esophageal adenocarcinoma is an effective strategy for patients including those either refusing esophagectomy or not a candidate for surgical intervention.
  • Clinicians should bear in mind the cost effectiveness and quality of life that endoscopic therapy affords.
  • What do patients need to know?

  • Endoscopy is an effective alternative to surgery for treating esophageal cancer.
  • Endoscopy offers a better quality of life after cancer removal.
  • Read the Abstract

    Author Contact
    Daryl Ramai, MD, The Brooklyn Hospital Center
    dramai [at] tbh [dot] org

    Media Interview Requests
    To arrange an interview with any ACG experts or abstract authors, please contact Becky Abel of ACG via email at mediaonly [at] gi [dot] org or by phone at 301-263-9000.